Meta AnalysisID 3711

去氧肾上腺素对比去甲肾上腺素在脓毒症患者中的应用:一项Meta分析

CRD42022372008

Will the use of phenylephrine improve mortality and also have beneficial outcomes in septic shock management compared to norepinephrine use

Back to Browse

Relationship Network

Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.

Click a node to open it in a new tab
Ingredient: 1Meta-analysis: 1Links: 1
Arranging relationship network...

Record Fields

Scalar fields from the final meta_analysis record.

Meta Analysis Id
3711
Evidence Id
12269
Core Evidence Id
12269
Source Meta Analysis Id
3669
Herb2 Meta Analysis Id
HBMA003669
Crd Id
CRD42022372008
Title
Use of Phenylephrine Compared to Norepinephrine In Patients With Sepsis; A Meta-analysis
Review Question
Will the use of phenylephrine improve mortality and also have beneficial outcomes in septic shock management compared to norepinephrine use
Study Type Included
RCT, retrospective and prospective cohort studies,
Condition Being Studied
Sepsis, septic shock
Participant
Patients who have a diagnosis of sepsis and require vasopressor use, specifically norepinephrine or phenylephrine
Animal
Human Disease Modelled
Intervention
A comprehensive literature search of PubMed and EMBASE will be conducted and all relevant studies that compared phenylephrine to norepinephrine in sepsis patients will be included. The eligibility criteria are follows: study was published in a peer-reviewed journal; the design was either retrospective/prospective cohort study or randomized control study that compared phenylephrine use and norepinephrine use in sepsis patients Exclusion criteria are as follows: study was not published in a peer reviewed journal
Comparator Control
The patient who are using norepinephrine will be the control for this study which looks into the phenylephrine population.
Main Outcome
Our primary outcome is in-hospital mortality. 30-day mortality will be alternatively used if data for in-hospital mortality is not available.
Outcome Measure
Additional Outcome
Our secondary outcomes are change in heart rate, hospital and intensive care unit length of stay.
Study Method
Meta-analysis, Systematic review
Keyword
Humans
Contact
Yoshiko Ishisaka [email protected]
Organisational Affiliation
Mount Sinai Beth Israel
Funding Source
Other Selection Criteria
Final Publication
Same Topic Review
Published Protocol
Review Type
Language
English
Country
Japan, United States of America
Review Stage
Review Ongoing
First Submission Date
2022-11-01
Registration Date
2022-11-11
Anticipated Start Date
2022-11-09
Anticipated Completion Date
2023-01-31
Title Cn
去氧肾上腺素对比去甲肾上腺素在脓毒症患者中的应用:一项Meta分析
Title En
Use of Phenylephrine Compared to Norepinephrine In Patients With Sepsis; A Meta-analysis
Bilingual Status
complete